Arkadiusz Rudawski, PhD posted this:
Technology Broker at Center for Technology Transfer, Cracow University of Technology
Universitat Politècnica de Catalunya - UPC posted this:Novel actuation system for an active orthosisA novel actuation system for a knee orthosis has been designed and patented. This new technology allows to actuate or lock knee rotation during gait, by means of a single motor and a ball-screw transmission. The system is lowweight, compact and easy to adapt to commercial passive orthoses. Partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.
Consejo Superior de Investigaciones Científicas posted this:Biocompatible self-generating cell stimulatorCSIC through the Instituto de Microelectrónica de Barcelona - Centro Nacional de Microelectrónica, has developed a device based on nanogenerators for electrical cells stimulation without the need of electrodes or bulky devices. The device is biocompatible and, among its multiple applications, is able to actuate in medical prostheses as enhancer of cellular growth and proliferation, which permits an early lesion recovery (such as a fracture or wound). Industrial partners dedicated to the development of medical devices for cells stimulation, in particular, focused onto therapeutic treatments of non-healing wounds, are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones Científicas posted this:Biocompatible self-generating cell stimulatorCSIC through the Instituto de Microelectrónica de Barcelona - Centro Nacional de Microelectrónica, has developed a device based on nanogenerators for electrical cells stimulation without the need of electrodes or bulky devices. The device is biocompatible and, among its multiple applications, is able to actuate in medical prostheses as an enhancer of cellular growth and proliferation, which permits an early lesion recovery (such as a fracture or wound). Industrial partners dedicated to the development of medical devices for cells stimulation, in particular, focused onto therapeutic treatments of non-healing wounds, are being sought to collaborate through a patent license agreement.
UACOOPERA University of Aveiro posted this:
Technology Transfer Office at uacoopera
Universitat de Lleida posted this:LapC-FORCE: Surgical device to improve laparotomy closure for incisional hernia preventionA multidisciplinary team involving doctors and engineers developed a medical device to cover the surgeons’ need at the moment of closing a laparotomy. With real-time information on force and distance, surgeons may decide the most appropriate closure technique and materials to be used for each single patient for reducing the laparotomy’s closing force and therefore, to prevent incisional hernias. We currently have a prototype medical device that measures the closing force between edges in a laparotomy. It was designed and tested in non-regulatory preclinical trials using pigs. We are looking for an industrial partner with expertise in the sector of medical devices willing to add in its product pipeline a new surgery device to assist surgeons during a laparotomy. The type of partner sought is mainly for regulatory development and commercialization under a technology license agreement.
Cracow University of Technology posted this:Hydrocolloid nanocomposite and production method thereof. Product is dedicated for superficial wounds in a shape of platesNanostructured silver is suspended in the gelling environment, which is a precursor of a colloidal system. A gelatin which is a natural protein polymer is a gelling environment. Nanosilver, due to its characteristics is widely used. The best-known advantage of silver nanoparticle is its antibacterial activity.
Universidad de Alcalá-OTRI posted this:Double port injector to corneal transplant DMEKThe Reseacrh group in Cell biology of solid tumors and tisular regeneration from Alcala University and the Research group in Cellular Engineering from University from Hospital La Paz, have developed a new injector designed to reduce endotellial damage during the corneal endothelial graft implantation in eye´s anterior chamber. The group is looking for cooperation or commercial agreement with companies manufacturers of sanitary products and medical devices, ophthalmological clinics and hospitals.
Boris Zubry posted this:
DIT Hothouse posted this:Optimisation of Posterior Spinal Dynamic (PSD) Stabilisation SurgeryOptimising spinal surgery techniques through the use of a hip and spine simulator and a tension and torsion test machine to treat spinal patient such as those with crushed vertebra and spinal deformities, like scoliosis.
Universidad de Alcalá-OTRI posted this:Double mesh prosthesis that corrects defects in the abdominal wall and prevents adhesion formation at the peritoneal interfaceA research group from the Surgery Department of Alcala University has designed an implantable prosthesis made of two meshes joined together, for abdominal surgery uses. This prosthesis prevents the erosion of the viscera by promoting mesothelial deposition. Both meshes induce fibroblast proliferation and collagen deposition achieving the definitive repair of the defect at the expense of connective tissue. This research group is looking for manufacturing and license agreements.
Technology Transfer OfficeView Profile
Biomedicine and Biotechnology Center - Leipzig University posted this:Peptide for Titanium and Biomaterial Surface Coating for Enhanced OsseointegrationOur research involves the modification of a recently patented molecule that contains L-3,4-dihydroxyphenylalanine (DOPA) and other bonding peptides to increase osseointegration on metal surfaces, particularly titanium. Lab results show that when coated with this molecule, titanium surfaces showed increased signs of bio-compatibility, which is backed up by published scientific research. The technology has the potential of improving osteosynthesis and orthopedic implants, as well as many other types of surgical implants. The BBZ is looking for licensing, joint R&D, or ownership opportunities regarding this technology.
IDIBELL posted this:Companion diagnostic for cutaneous and uveal melanomaCompanion diagnostic for cutaneous and uveal melanoma. Our combination drug therapy for metastatic melanoma offers an alternative treatment for patients that do not have the BRAF V600 mutation or for patients resistant to Vemurafenib. Additionally, our technology can be used as a prognostic test to predict the risk of metastasis in uveal and cutaneous melanoma.